Healthcare
Gilde Healthcare opens DACH office in Frankfurt
German team will be expanded with additional investment professionals over the next 12 months
Primer Capital et al. in €1.7m round for Acticor Biotech
GPs and private investors back the French biotechnology company researching thrombotic diseases
Ming et al. in €25m series-D round for Miracor Medical
Belgian public investors SFPI, SRIW and Meusinvest grant a non-dilutive cash advance
VC firms inject CHF 20m into Oculis
Company simultaneously announces the relocation of its headquarters from Reykjavik to Lausanne
Principia et al. in €32m series-D round for Enterome
Company also nets a €40m credit line provided by the European Investment Bank
Oaktree buys NL Holding
Group comprises 16 subsidiaries in Germany, the Czech Republic, Italy, Switzerland and Spain
Funds back $270m series-A for BioNTech
Struengmann Family Office commits fresh capital to the round and retains a majority stake
Riverside invests in Alter Pharma
GP is currently investing from its fifth fund, which targets businesses with EBITDA of €5-15m
VC firms in £85m series-B for Orchard Therapeutics
Fresh capital will be used for the global launch of the company's lead gene therapy product
ECM buys urology specialist Uroviva
ECM draws equity for the transaction from its €230m buyout fund German Equity Partners IV
Hadean Ventures holds €35m first close for debut fund
VC firm is planning on completing a first deal with a Nordic startup in Q1 2018
August Equity acquires dental practices for £5.75m
Second acquisition in the strategy after the GP acquired Genesis Dental Care in May
Terra Firma's Four Seasons agrees interest payment standstill
Major creditor H/2 has agreed to the measure in order to facilitate a consensual restructuring
Magnum to acquire Indiba in SBO
GP to buy the Spanish electro-medicine manufacturer Indiba from Minerva for around €60m
Waterland-backed Schönes Leben Group buys Compassio
Acquisition of Compassio is the first step in Waterland's new buy-and-build strategy
Forbion, BGV lead €25m series-A for NorthSea Therapeutics
Fresh capital will be used to conduct a phase IIb clinical study in preparation for phase III
Duke Street exits Baywater after four-year holding
Buyout of Baywater Healthcare was Duke Street's second deal-by-deal financing
LSP closes €280m healthcare fund
Fund is the largest in Europe dedicated purely to medical technology investments
Serendipity acquires 51% stake in Topro's German subsidiary
PE firm acquires majority stake, while a minority stake is acquired by Investinor
Serendipity buys majority stake in Evondos
Growth plans are likely to include expansion in the Nordic and other European markets
VC firms in $59.6m series-C for Hookipa
New investors include HB Partners, Hillhouse Capital, Sirona Capital and Gilead Sciences
Crescent-, Viridian-backed Fusion Antibodies to list on AIM
Northern Irish biotech company will use the capital to invest in its laboratories and manufacturing
HealthCap backs Doctrin in $10m series-A
Funding round was led by Swedish healthcare provider Capio alongside other investors
Mercia invests £2.5m in Medherant
Investment is part of a ТЃ3.8m funding round from other private investors and existing shareholders